Transforming growth factor-j? (TGF-j?) and macrophage inflammatory protein-la (MIP-la) are both well-described inhibitors of committed and multipotential hematopoietic progenitors. The effect of these cytokines on true stem cell activity in ex vivo culture systems as assayed by murine long-term repopulating activity (LTRA) has not been examined. We studied the stem cell effects of the addition of these cytokines to ex vivo cultures containing interleukin-3 (IL-31, IL-6, and stem cell factor (SCF), using the murine competitive repopulation assay. We also tested the impact of adding an anti-TGF-P neutralizing antibody, to ask whether abrogation of autocrine/paracrine TGF-j? may protect or enhance RANSFORMING growth factor-ps (TGF-0s) are a
T group of pleiotropic cytokines with significant effects on hematopoiesis."* Of the three mammalian isoforms, TGF-P l is the best characterized. But recent reports have shown that TGF-P3 is also important in hematopoietic reg~lation.~ These cytokines have a complex array of inhibitory and stimulatory activities in the hematopoietic and immune syst e m~.~.~ The type of activity may be dependent on the differentiation stage of the target cell population. ' The recently reported TGF-P1 knockout mouse model has shown the prominent role for this cytokine in preventing hyperactive inflammatory responses and immune system over activity. ' Many investigators have explored the effects of TGF-0s on hematopoietic progenitor cells. The plating efficiencies of differentiated, single-lineage committed progenitors such as colony-forming unit-erythroid (CFU-E), CFU-granulocyte (CFU-G), and CFU-macrophage (CFU-M) are stimulated.' But more immature multipotential progenitors such as CFU-granulocyte, erythroid, macrophage, megakaryocyte (CFU-GEMM), high proliferative potential-colony-forming cell (HPP-CFC), and CFU-spleen (CFU-S) are inhibited, and these actions can be modified by specific combinations or temporal sequences of administration of stimulatory cytokines."." Human long-term culture initiating cells (LTCIC) are also inhibited. ' '-I3 Administration of pharmacologic doses of TGF-PI to mice in vivo decreases platelet and red blood cell numbers but increases leukocyte c o~n t s . '~ The origin of TGF-Ps in the hematopoietic microenvironment is also complex. They are produced by stromal elements as well as by hematopoietic progenit~rs.'~''~ The balance of autocrine and paracrine positive and negative regulators present in the microenvironment, both in vivo or during ex vivo culture, presumably has a major impact on the homeostasis of hematopoietic cell production.
Macrophage inflammatory protein-la (MIP-la) is one of the family of chemokines produced by macrophages, and has also been called "stem cell inhibitor."16 This cytokine inhibits immature multipotential CFU-S and CFU-A.I6 Although there is clear evidence that MlP-la inhibits stem cell factor-induced proliferation of human CFU-GM and burstforming units-erythroid, other investigators have shown both inhibitory or stimulatory actions on committed progenitors depending on the other cytokines used to support colony the survival of LTRA during ex viva culture. TGF-Pl had significant suppressive effects on both short-and long-term repopulating activities, and anti-TGF-6 antibody had enhancing effects compared with control cultures containing IL-3, IL-6, and SCF alone. MIP-la had no significant effects on either short-or long-term repopulating ability. These data suggest that abrogation of TGF-p during suspension culture may allow enhanced survival or even expansion of primitive cells ex vivo, with implications for many applications, including gene therapy. This is a US government work. There are no restrictions on its use.
formation in v i t r~. "~'~ Inhibitory actions on committed progenitors have also been reported after in vivo administration, and protection of progenitors from chemotherapy-induced cytotoxicity has also been demon~trated.'~*~~ Thus, MIP-la has been classified as one of the main inhibitory hematopoietic cytokines along with TGF-Ps. But more recent reports studying more primitive LTCIC and/or purified progenitor populations have found evidence for a stimulatory or protective role for MIP-la during ex vivo culture.18~21~22
Thus far there have been no investigations of the effects of TGF-0s or MIP-la on true long-term repopulating stem cell activity. This knowledge could be critical for ex vivo expansion or gene therapy applications directed at hematopoietic progenitor or stem cells, especially because there is strong evidence for autocrine and paracrine production of these cytokines by hematopoietic and microenvironmental cell^.^.'^ Thus, we designed a series of experiments focusing on the effects of TGF-P, MIP-la, or anti-TGF-P on ex vivo culture of murine stem cells, using the murine competitive repopulation assay system that allows quantitation of true long-term repopulating a~t i v i t y . '~.~~ 4562 SOMA, YU, AND DUNBAR essential medium with 4 mmol/L glutamine. 50 mg/mL penicillin, and 50 mg/mL streptomycin, (all from GIBCOIBRL, Gaithersburg, MD). and 15% fetal calf serum (Hyclone, Logan, UT) dispersed to a single-cell suspension by passage through a 21-gauge needle. BM cells were cultured at 5 X 10' nucleated cellslmL in D15 medium with cytokines on non-tissue culture treated 100-mm dishes (Sarstedt. Princeton, NJ). Murine interleukin-3 (IL-3; Genzyme. Boston, MA), human IL-6 (Amgen, Thousand Oaks, CA), and rat stem cell factor (Amgen, Thousand Oaks, CA) were added to every culture at concentrations of 10 ng/mL. 50 nglmL, and 100 ng/mL, respectively. Some C57BW6J cultures had purified natural human TGF-Dl at 5 ng/mL or murine MIP-la at 100 ng/mL added (R&D Systems, Minneapolis. MN). Other C57BL/6J plates had anti-TGF-8 I .2,3 murine monoclonal antibody (MoAb; Genzyme) added at 20 pglmL. which inhibits up to 2.5 nglmL of TGF-Dl activity. This antibody has been shown to be neutralizing in both ex vivo and in vivo assays." Control polyclonal mouse IgG was added to some control plates of HW80 cells. After 4 days of incubation at 37°C. 5% COz. the BM cells were collected from the HW80 and C57BL/6J plates, counted, and pooled for each experimental competitive condition. C57BU6J cells (either treated with TGF-0, MIP-la, anti-TGF antibody or no addition) were mixed with cells representing the same initial dosage (same plate equivalent) of nontreated or isotype control-treated HW80 cells. Cells were injected via tail vein into nonirradiated W/ W' recipient mice. The total number of cells injected ranged from 0.85 to 1.5 X IOh per WIW' recipient, corresponding to 5 X IOr' cells initially plated.
Heparinized peripheral blood (PB) was obtained from the retro-orbital sinus every 2 to 4 weeks. Hemoglobin (Hb) phenotype was determined by cellulose acetate electrophoresis of heparinized PB as previously described, using reagents and a CliniScanII instrument from Helena Laboratories (Helena Laboratories, Beaumont, TX).'" The relative repopulating ability of the HW80 (control) compared with the C57BL/6J (treated or control) marrow was determined by the relative intensities of the Hb diffuse (HW80) versus Hb single (C57BL/6J) bands.
CFII-S12 nssciy. The CFU-SI2 assay was performed by the method of Till and McCulloch.'" WBB6FI -+/+ recipients received 900 rads total body irradiation using a '17Cs gamma irradiator. Within 2 to 4 hours, the mice were injected with 100 to 1O.ooO cultured marrow cells via the tail vein. Twelve days later the spleens were removed and fixed in 70% ethano1:acetic acid:formalin at 20:1:1, and macroscopic CFU-SI, colonies were counted. Cultured marrow cells were plated at 10, OOO to 100,000/mL in murine methylcellulose media (Stemcell Technologies Inc. Vancouver, Canada) containing 3 U/mL human erythropoietin (Amgen. Thousand Oaks, CA) and 10% WEHI-3B-conditioned media. Colonies of greater than 50 cells were counted after incubation at 37°C in 5% CO2 for 14 days.
At least 4 months after transplantation, recipient WIW' mice were killed and high-molecular-weight DNA was extracted from the thymus and BM. BM and thymus DNA was digested with EcoRl (GIBCOI BRL) and probed with a 61 I-bp Psr I/ BamHI fragment from the second intervening sequence of the murine murine Hb gene as described. 27 The two p"ple alleles (C57BLI 63) have an expected fragment size of 10 kb, whereas the ~l ' " " Y alleles (pmnJ"'and p'"'") have expected fragment sizes of 14 kb and 7 kb. with the probe hybridizing well only to the 7-kb allele.
Statistical significance was assessed by the two-tailed Student's t-test using Statviewll computer software (Abacus Concepts, Sunnyvale. CA).
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Design qf competitive repopulation assay. We tested the effect of altering TGF-,B o r MIP-la levels under ex vivo Dl -containing cultures had CFU-C and CFU-S decreased by 82% and 73%, respectively. MIP-la only marginally decreased the yield of CFU-S and CFU-C, and this effect was not statistically significant.
Every 2 to 4 weeks, Hb phenotype was analyzed by cellulose acetate electrophoresis and quantitated by densitometry. Data on short-term repopulation (40 to 60 days posttransplantation) in four separate experiments are shown in Table  1 . The percent pIlncle Hb, corresponding to the repopulation of the erythroid compartment derived from the "treated" (CS7BW6J) marrow, is shown. At these early time points, there was a strong inhibitory effect of TGF-PI and an opposite positive effect of anti-TGF-P antibody. MIP-la had no significant effect. Data shown are mean % lib"'""'" t SD in the PE of each set of animals.
P < ,001.
t P < .01.
* P < .05.
were similar to those noted at the shorter-term time points, but variability from animal to animal increased, especially in the animals receiving TGF-PI -treated marrow. Again, MIP-la had no stimulatory or inhibitory effects. Figure 3A shows reconstitution over time for each of the four experiments. expressed as the mean Hb""F'' value for each experimental group of mice (CS7BW6J marrow cultured with the addition of either TGF-PI or anti-TGF-P antibody competed against HW80 cultured under standard conditions or with control antibody) divided by the mean value for each control group of mice (C57BU6J marrow cultured under standard conditions competed against HW80 marrow cultured under standard conditions or with control antibody) at each time point. A ratio of 1.0 means that the experimental group of mice had no difference in reconstitution compared with the control group of mice that received marrow of both types incubated under identical conditions. All four experiments found that anti-TGF-P antibody-containing cultures produced relatively constant enhancement of reconstitution compared with standard culture conditions over the whole time period, although the absolute levels varied between experiments, suggesting a uniform protective activity on both long-and short-term reconstituting abilities. The most potent inhibitory effects of TGF-PI were seen in the first 2 to 3 months, with some dispersion of later values. Figure 3B shows the same reconstitution time course for MIP-la-treated marrow. MIP-la was neither inhibitory nor stimulatory under our experimental conditions.
Individual animals receiving TGF-P-cultured marrow in all four experiments began to develop more marked variability in results after day 60 to 90 posttransplantation, leading to loss of statistical significance although maintenance of an overall inhibitory effect. The anti-TGF-P antibody and MIP-la animals did not show this individual variability. This increased variability in the TGF-P group might be explained by a decreased number of functional long-term repopulating cells present after culture in the presence of TGF-P, leading to repopulation by a very small number of C57BL/ 65 clones and thus marked changes in Hbsingle levels over time in individual animals as well as marked differences between animals in these groups.
HVIttgk
DNA analysis of reconstitution patterns of other hematopoietic lineages. Other investigators have verified that erythroid reconstitution is representative of reconstitution in other nonerythroid hematopoietic lineages in the W W competitive repopulation assay. 29 We also validated our Hb reconstitution results by analyzing the relative proportions of the P-Hb gene alleles present in other hematopoietic tissues at least 120 days posttransplantation. Figure 4 shows a Southem blot analysis of DNA derived from BM spleen and thymus of reconstituted animals. A P-Hb probe was used that discriminates between the patterns of P-Hb alleles found in the two donor strains. These band pattems can be seen in lanes representing the two donor (HW80 and C57BL/6J) and the W W WBBFl recipient strains. Animals receiving TGF-PI -cultured marrow competed against standard conditions had dominant bands corresponding to the Hb phenotype's alleles (pmaJor and ,Bminor), concordant with the Hb data and indicating that culture of marrow in TGF-PI was inhibitory to reconstitution in multiple lineages. Similar confirmatory results were seen in the anti-TGF-P animals, with a dominant band corresponding to the phenotype. Quantitation of the densities of Southern blot bands and the corresponding Hbsingle bands on cellulose acetate electrophoresis are also shown. The numbers correlate well, indicating similar effects of either the TGF-Plor the anti-TGF-P cultures on myeloid, erythroid, T-cell, and B-cell lineages.
DISCUSSION
In our experiments, we have shown that TGF-01 is inhibitory to long-term repopulating activity (LTRA) in ex vivo suspension culture, and that addition of anti-TGF-P antibody can improve LTRA compared with standard supematant cultures containing 1L-3, IL-6, and SCF alone. This expands the known levels of activity of this cytokine to the most primitive repopulating cells, beyond effects on progenitor cells previously described by other investigators.
A recent study reported that TGF-PI downregulates c-kit expression on both immortalized progenitor cell lines and primary BM cells.'"." Because SCF signaling via c-kit upregulates the sensitivities of progenitor cells to various stimulatory cytokines, it is quite probable that TGF-,O participates in negative regulation of hematopoiesis through downregulation of cytokine receptors. SCF and other stimulatory cytokines probably exert much of their stimulatory or protective activities via inhibition of apoptosis. A recent study reported that the viability of purified murine Lin-Scal' hematopoietic cells was compromised by the inclusion of TGF-P during culture with SCF or granulocyte colony-stimulating factor.32 These cells were shown to undergo apoptosis more frequently in the presence of TGF-P , and anti-TGF-P antibody was shown to be protective. These data correlate well with our functional data on actual LTRA.
Our results showing a protective or stimulatory effect of the inclusion of a neutralizing anti-TGF-P antibody during ex vivo culture suggests that autocrine or paracrine production of TGF-Ps by marrow elements may be an important negative regulator of hematopoiesis and impediment to successful ex vivo expansion or gene transduction. Antisense oligonucleotides to TGF-P have been shown to enhance colony formation by purified human progenitor cells, suggesting a direct autocrine loop involving this cytokine on primitive progenitor cells.'' Individual sorted primitive murine hematopoietic cells also have been shown to have enhanced viability in cultures containing the neutralizing antibody, further supporting a significant component of autocrine regulation of primitive progenitors by TGF-p.32 In addition, marrow stromal elements also produce TGF-Ps. In long-term Dextertype cultures, concentrations of TGF-0s were as high as 2 to 5 ng/mL I day after media change.'* Our experiments used nonfractionated marrow cclls, thus we cannot distinguish autocrine from paracrine effects.
Another interesting feature observed in our experiments were the temporal patterns of the effects of TGF-PI versus anti-TGF-P antibody. The suppressive effect of TGF-01 appeared to be strongest on short-term reconstituting cells. and eventually weakened and became more variable. On the other hand, anti-TGF-8 neutralizing antibody appeared to be more consistently protective of both short-and long-term repopulating activities. These differences suggest that shortterm reconstituting cells may be more susceptible to exogenous TGF-01 than long-term repopulating cells because of a greater reliance on ex vivo stimulation through SCFlc-kit interactions or other pathways. The presence of large amounts of TGF-01 may induce the most primitive cells to in some way modulate their cell-cycle status or responsiveness to cytokines in such a way as to be relatively protected. The presence of the neutralizing antibody may instead allow both short-and long-term repopulating cells to remain protected from a much lower endogenous production level.
It is also possible that autocrine or paracrine TGF-P2 or 3 are responsible for inhibition of the most primitive longterm repopulating cells, and that the antibody was effective due to neutralization of all three isoforms, whereas addition of TGF-P 1 had its strongest effects only on short-term reconstituting cells.
We have also shown that inclusion of MIP-la did not have inhibitory or stimulatory actions on LTRA under our experimental conditions. Other investigators have shown that MIP-la does not have inhibitory actions on more primitive human progenitors despite marked inhibition of CFU-GM formation in the presence of IL-3." In fact, it has been reported that MIP-la allowed better maintenance of human LTClC in extended cultures including a stromal layer." When MIP-la was administered to mice just after treatment with 5-FU. LTRA was not protected from a second dose of 5-FU administered 7 days later, suggesting that the MIP-la did not prevent stem cells from going into cell cycle after the first dose of 5-FU." This lack of an in vivo effect on stem cell activity, despite activity in the same experiment on more committed progenitor cells, agrees with our conclusions. After in vivo administration. both MIP-I a and TGF-PI have shown an ability to protect against the immediate myelosuppressive effects of subsequently administered chemoIt is hypothesized that this is due to prevention of cycling of progenitor cells and thus protection from killing by cell-cycle-specific agents. These in vivo experiments document a marked contrast between in vivo and in vitro effects of these cytokines. In vitro, progenitor and stem cells are exposed to cytokines, both stimulatory and inhibitory, without the usual microenvironmental components that may completely alter the response of cell populations to these influences in vivo. The addition of as yet unknown soluble factors produced by stromal cells or inclusion of adhesive molecules such as fibronectin may further improve the survival or proliferation of stem cells during ex vivo culture.". '5 Efficient gene transfer to true repopulating stem cells, especially in large animals or humans, has proven very diffic~lt.'~.'' The most commonly used vector systems depend on the target cell going through S phase to integrate vector genes into the genome." A major hurdle to effective gene therapy may be the fact that primitive hematopoietic stem cells are not commonly in S phase."' Existing ex vivo suspension culture systems using cocktails of hematopoietic cytokines are very efficient at cycling and expanding committed 4 ' Thus, an understanding of the function of inhibitory cytokines in the context of stem cell biology may yield important new approaches to improving LTRA and stem cell gene transfer. Abrogation of the effects of TGF-P or other inhibitory cytokines may allow more successful ex vivo culture or even expansion of LTRA for gene therapy or stem cell transplantation applications. Primitive cells pushed into cycle may go through apoptosis if TGF-P is present, and ex vivo culture may stimulate the autocrine production of TGF-P for some reason.
It will be important in the future to clarify the mechanism of the effects observed in our studies. The use of purified progenitor and stem cell populations will allow us to study apoptosis, growth factor receptor and ligand expression, and LTRA in response to TGF-P and anti-TGF-P exposure. These studies may also provide important information about maintenance and deviation from quiescence of LTRAs, which is an essential issue in hematologic gene transfer and ex vivo expansion applications.
